Analysis of IGH allele content in a sample group of rheumatoid arthritis patients demonstrates unrevealed population heterogeneity.

germline gene variation haplotyping immunoglobulin heavy chain polymorphism population genetics recombination signal sequence rheumatoid arthritis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 18 10 2022
accepted: 09 01 2023
entrez: 17 2 2023
pubmed: 18 2 2023
medline: 22 2 2023
Statut: epublish

Résumé

Immunoglobulin heavy chain (IGH) germline gene variations influence the B cell receptor repertoire, with resulting biological consequences such as shaping our response to infections and altering disease susceptibilities. However, the lack of information on polymorphism frequencies in the IGH loci at the population level makes association studies challenging. Here, we genotyped a pilot group of 30 individuals with rheumatoid arthritis (RA) to examine IGH allele content and frequencies in this group. Eight novel IGHV alleles and one novel IGHJ allele were identified in the study. 15 cases were haplotypable using heterozygous IGHJ6 or IGHD anchors. One variant, IGHV4-34*01_S0742, was found in three out of 30 cases and included a single nucleotide change resulting in a non-canonical recombination signal sequence (RSS) heptamer. This variant allele, shown by haplotype analysis to be non-expressed, was also found in three out of 30 healthy controls and matched a single nucleotide polymorphism (SNP) described in the 1000 Genomes Project (1KGP) collection with frequencies that varied between population groups. Our finding of previously unreported alleles in a relatively small group of individuals with RA illustrates the need for baseline information about IG allelic frequencies in targeted study groups in preparation for future analysis of these genes in disease association studies.

Identifiants

pubmed: 36798124
doi: 10.3389/fimmu.2023.1073414
pmc: PMC9927645
doi:

Substances chimiques

Immunoglobulin Heavy Chains 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073414

Informations de copyright

Copyright © 2023 Hardt, Corcoran, Narang, Malmström, Padyukov and Karlsson Hedestam.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Immunol. 2020 Sep 23;11:2136
pubmed: 33072076
Cell. 2015 Nov 5;163(4):947-59
pubmed: 26593423
Data Brief. 2017 Jun 27;13:620-640
pubmed: 28725665
Nat Commun. 2017 May 11;8:14946
pubmed: 28492228
Immunity. 2021 Feb 9;54(2):355-366.e4
pubmed: 33484642
J Immunol. 2010 Jun 15;184(12):6986-92
pubmed: 20495067
Best Pract Res Clin Rheumatol. 2001 Mar;15(1):1-15
pubmed: 11358411
Autoimmunity. 1996;24(4):257-63
pubmed: 9147584
J Clin Invest. 1996 May 15;97(10):2277-82
pubmed: 8636407
Nucleic Acids Res. 2015 Jan;43(Database issue):D413-22
pubmed: 25378316
Nature. 2019 Oct;574(7776):122-126
pubmed: 31554970
Front Immunol. 2016 Nov 04;7:457
pubmed: 27867380
Front Immunol. 2019 Apr 05;10:660
pubmed: 31024532
J Clin Invest. 1991 Jul;88(1):193-203
pubmed: 1676037
Nat Genet. 2012 Dec;44(12):1336-40
pubmed: 23143596
Nature. 2015 Oct 1;526(7571):75-81
pubmed: 26432246
Trends Immunol. 2017 Jul;38(7):459-470
pubmed: 28539189
Genes Immun. 2021 Aug;22(4):205-217
pubmed: 34175903
Nat Methods. 2021 Jun;18(6):588-591
pubmed: 34002093
PLoS Comput Biol. 2016 Jan 11;12(1):e1004409
pubmed: 26751373
Front Immunol. 2021 Feb 24;11:603980
pubmed: 33717051
Nat Immunol. 2015 Jul;16(7):755-65
pubmed: 26006014
Mol Cell. 2018 Apr 19;70(2):358-370.e4
pubmed: 29628308
Nucleic Acids Res. 2020 Jun 4;48(10):5499-5510
pubmed: 32365177
J Clin Invest. 1995 Sep;96(3):1591-600
pubmed: 7657830
Mol Immunol. 2017 Jul;87:12-22
pubmed: 28388445
Curr Opin Struct Biol. 2018 Dec;53:178-186
pubmed: 30476719
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2567-75
pubmed: 24821781
J Immunol. 2012 Feb 1;188(3):1333-40
pubmed: 22205028
Arthritis Res. 2002;4 Suppl 3:S31-6
pubmed: 12110121
Lupus. 2003;12(5):400-5
pubmed: 12765304
Am J Hum Genet. 2013 Apr 4;92(4):530-46
pubmed: 23541343
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1901-1906
pubmed: 29432186
J Immunol. 1992 Oct 1;149(7):2337-44
pubmed: 1382098
Blood. 1986 Aug;68(2):430-6
pubmed: 2425869
Proc Natl Acad Sci U S A. 1976 Oct;73(10):3628-32
pubmed: 824647
Eur J Immunol. 1994 Dec;24(12):2941-9
pubmed: 7805720
Genes Immun. 2012 Jul;13(5):363-73
pubmed: 22551722
PLoS Comput Biol. 2019 Jul 22;15(7):e1007133
pubmed: 31329576
Nat Commun. 2016 Dec 20;7:13642
pubmed: 27995928
N Engl J Med. 2004 Jun 17;350(25):2572-81
pubmed: 15201414
Genome Res. 2002 Apr;12(4):656-64
pubmed: 11932250
Nat Immunol. 2022 Jul;23(7):1-10
pubmed: 35761085
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Sci Rep. 2016 Feb 16;6:20842
pubmed: 26880249
Nat Commun. 2019 Feb 7;10(1):628
pubmed: 30733445
J Exp Med. 1998 Dec 7;188(11):2151-62
pubmed: 9841928
J Immunol. 1998 Dec 1;161(11):6068-73
pubmed: 9834090
J Clin Invest. 1995 Apr;95(4):1766-72
pubmed: 7706484
Biochem J. 1996 Mar 1;314 ( Pt 2):621-30
pubmed: 8670078
Immunol Rev. 2018 Jul;284(1):9-23
pubmed: 29944765
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Nat Rev Genet. 2019 Aug;20(8):467-484
pubmed: 31068683
Nucleic Acids Res. 2022 Nov 11;50(20):11696-11711
pubmed: 36370096
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E862-70
pubmed: 25675496
Ann Rheum Dis. 2014 Apr;73(4):756-62
pubmed: 23606709
Semin Immunopathol. 2022 Jan;44(1):47-62
pubmed: 35088123

Auteurs

Uta Hardt (U)

Division of Rheumatology, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden and Karolinska University Hospital, Stockholm, Sweden.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Martin M Corcoran (MM)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Sanjana Narang (S)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Vivianne Malmström (V)

Division of Rheumatology, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden and Karolinska University Hospital, Stockholm, Sweden.

Leonid Padyukov (L)

Division of Rheumatology, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden and Karolinska University Hospital, Stockholm, Sweden.

Gunilla B Karlsson Hedestam (GB)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH